Affimed N.V. (AFMD): Price and Financial Metrics
Affimed N.V. (AFMD)
Today's Latest Price: $5.13 USD
0.02 (0.39%)
Updated Nov 24 4:00pm
Add AFMD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AFMD Stock Summary
- Of note is the ratio of Affimed NV's sales and general administrative expense to its total operating expenses; just 9.36% of US stocks have a lower such ratio.
- For AFMD, its debt to operating expenses ratio is greater than that reported by only 8.73% of US equities we're observing.
- Revenue growth over the past 12 months for Affimed NV comes in at 171.6%, a number that bests 96.46% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Affimed NV, a group of peers worth examining would be SPRO, CDTX, GRTS, CBIO, and VIR.
- AFMD's SEC filings can be seen here. And to visit Affimed NV's official web site, go to www.affimed.com.
AFMD Stock Price Chart Interactive Chart >
AFMD Price/Volume Stats
| Current price | $5.13 | 52-week high | $5.24 |
| Prev. close | $5.11 | 52-week low | $1.42 |
| Day low | $4.96 | Volume | 1,200,100 |
| Day high | $5.24 | Avg. volume | 1,124,027 |
| 50-day MA | $3.71 | Dividend yield | N/A |
| 200-day MA | $3.18 | Market Cap | 391.16M |
Affimed N.V. (AFMD) Company Bio
Affimed NV is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company was founded in 2000 and is based in Heidelberg, Germany.
Loading social stream, please wait...